Scientist evaluating protein-based drugs with mass spectrometry need to manage difficulties consisting of analyte ion circulation over multiple charge states. The ZenoTOF 7600 system is a high-resolution mass spectrometry technology that pairs Zeno trap with electron triggered dissociation (EAD) and allows researchers to accelerate drug discovery and development programs by determining and localizing amino acid-specific post-translational adjustments (PTMs) throughout all charge states. In addition, researchers use this system to acquire highly detailed fragment info and extremely precise positional verification; dramatically boost fragment ion protection; and quickly and precisely produce undamaged and subunit results with confidence.Explore this material pack by SCIEX to achieveComprehensive analysis and characterization of next generation biologics, including monoclonal antibodiesEnhanced product quality characteristic investigationAdvanced protein therapeutic characterizationComprehensive differentiation and localization of PTMs, including glycosylation, deamidation, and sulfationSponsored by
